89 related articles for article (PubMed ID: 19060235)
1. Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
Mantovani G; Madeddu C; Cadeddu C; Dessì M; Piras A; Massa E; Serpe R; Antoni G; Mercuro G
Oncologist; 2008 Dec; 13(12):1296-305. PubMed ID: 19060235
[TBL] [Abstract][Full Text] [Related]
2. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular diastolic function with epirubicin therapy: an echodoppler study.
Maione S; Giunta A; Itri F; Losardo L; Palma M; Giacummo A; De Blasio F; De Matteis L
Int J Clin Pharmacol Ther Toxicol; 1992 Jun; 30(6):189-94. PubMed ID: 1612812
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.
Cadeddu C; Piras A; Mantovani G; Deidda M; Dessì M; Madeddu C; Massa E; Mercuro G
Am Heart J; 2010 Sep; 160(3):487.e1-7. PubMed ID: 20826257
[TBL] [Abstract][Full Text] [Related]
5. Acute cardiac functional and morphological changes after Anthracycline infusions in children.
Ganame J; Claus P; Eyskens B; Uyttebroeck A; Renard M; D'hooge J; Gewillig M; Bijnens B; Sutherland GR; Mertens L
Am J Cardiol; 2007 Apr; 99(7):974-7. PubMed ID: 17398195
[TBL] [Abstract][Full Text] [Related]
6. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
[TBL] [Abstract][Full Text] [Related]
7. Can the epirubicin cardiotoxicity in cancer patients be prevented by angiotensin converting enzyme inhibitors?
Radulescu D; Buzdugan E; Ciuleanu TE; Todor N; Stoicescu L
J BUON; 2013; 18(4):1052-7. PubMed ID: 24344038
[TBL] [Abstract][Full Text] [Related]
8. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
9. Assessment of early epirubicin cardiotoxicity in women with breast cancer.
Sobić-Saranović D; Pavlović S; Susnjar S; Neskovi c-Konstantinović Z; Jelić S
Anticancer Res; 1997; 17(5B):3889-91. PubMed ID: 9427798
[TBL] [Abstract][Full Text] [Related]
10. A stress echocardiography study of cardiac function during progressive exercise in pediatric oncology patients treated with anthracyclines.
De Souza AM; Potts JE; Potts MT; De Souza ES; Rowland TW; Pritchard SL; Sandor GG
Pediatr Blood Cancer; 2007 Jul; 49(1):56-64. PubMed ID: 17226848
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction.
Daugaard G; Lassen U; Bie P; Pedersen EB; Jensen KT; Abildgaard U; Hesse B; Kjaer A
Eur J Heart Fail; 2005 Jan; 7(1):87-93. PubMed ID: 15642537
[TBL] [Abstract][Full Text] [Related]
13. Acute administration of epirubicin induces myocardial depression in isolated rat heart and production of radical species evaluated by electron spin resonance spectroscopy.
Delemasure S; Sicard P; Lauzier B; Moreau D; Vergely C; Rochette L
J Cardiovasc Pharmacol; 2007 Dec; 50(6):647-53. PubMed ID: 18091581
[TBL] [Abstract][Full Text] [Related]
14. Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers.
Gupta M; Steinherz PG; Cheung NK; Steinherz L
Med Pediatr Oncol; 2003 Jun; 40(6):343-7. PubMed ID: 12692800
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction.
Plewka M; Krzemińska-Pakuła M; Lipiec P; Peruga JZ; Jezewski T; Kidawa M; Wierzbowska-Drabik K; Korycka A; Robak T; Kasprzak JD
Am J Cardiol; 2009 Nov; 104(10):1336-42. PubMed ID: 19892047
[TBL] [Abstract][Full Text] [Related]
16. Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer.
Appel JM; Sogaard P; Mortensen CE; Skagen K; Nielsen DL
J Am Soc Echocardiogr; 2011 Feb; 24(2):200-6. PubMed ID: 21227647
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer.
Zhang H; Shen WS; Gao CH; Deng LC; Shen D
Drugs R D; 2012 Jun; 12(2):101-6. PubMed ID: 22770377
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular function by 'conventional' and 'tissue Doppler' echocardiography in paediatric dialysis patients.
Civilibal M; Caliskan S; Oflaz H; Sever L; Candan C; Canpolat N; Kasapcopur O; Arisoy N
Nephrology (Carlton); 2009 Oct; 14(7):636-42. PubMed ID: 19796022
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines.
Radulescu D; Pripon S; Radulescu LI; Duncea C
Acta Cardiol; 2008 Feb; 63(1):27-32. PubMed ID: 18372577
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
